InvestorsHub Logo
Followers 839
Posts 120506
Boards Moderated 18
Alias Born 09/05/2002

Re: randychub post# 1273

Saturday, 07/07/2007 12:05:48 AM

Saturday, July 07, 2007 12:05:48 AM

Post# of 3757
>Dew at one time you thought that hep-b alone made the stock worth $15 or so a share.<

You must be thinking of Goldman Sachs, not me. In a May 2006 report, GS ascribed $13.40/sh of value to the HBV program alone (#msg-11336895).

My stated view from the same period was that the entire company less the HCV program — i.e. the HBV program, the HIV program, the drug-discovery engine per se, and the cash on the balance sheet — justified a share price in the low teens. Regards, Dew

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”